#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transient ischaemic attack Breast angiosarcoma B precursor type acute leukaemia Haemophilia A with anti factor VIII Turner's syndrome Scedosporium infection Vascular calcification Endometrial adenocarcinoma Neurodegenerative disorder Cushing's syndrome Graft versus host disease Transitional cell cancer of the renal pelvis and ureter Blood iron increased Acute graft versus host disease in skin Laryngeal squamous cell carcinoma More trials…

    Learn about Rare Diseases

    Hyperoxaluria Friedreich’s ataxia – Trials in Disease Rhabdomyosarcoma recurrent – Trials in Disease Short-bowel syndrome – Life with Disease Soft tissue sarcoma Phenylketonuria – Trials in Disease Myelodysplastic syndrome – Life with Disease Carcinoid syndrome Lennox-Gastaut syndrome – Diagnostics Haemophilia B with anti factor IX – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Keto-Leucine Calcium Fezolinetant SOFTISAN 378 PIPOTIAZINE S095035 Clomipramine Hydrochloride Carbidopa Bedaquiline Nitrogen Fluorouracil Pamapimod L-Arginine Hydrochloride REGN7999 Hydrocortisone Acetate Trientine Dihydrochloride Abc-15A-116 Exenatide Pegargiminase Fampridine Poa Pratensis Pollen Extract More therapies…

    Learn about Your Condition

    Small intestine adenocarcinoma CDKL5 deficiency disorder Sepsis HER2 negative breast cancer Eructation Cryoglobulinaemia Oropharyngeal cancer Deep vein thrombosis Rectal neoplasm Varicella Rubella Normal pressure hydrocephalus Colon cancer stage III Prostate cancer Pharyngeal cancer stage I More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Neurodegenerative disorder

  • Study on the Accuracy of Tau PET ([18F]RO6958948) and Vizamyl (Flutemetamol 18F) in Diagnosing Mild Cognitive Symptoms and Risk of Alzheimer’s Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cognitive disorder
    • Progressive supranuclear palsy
    • Prodromal Alzheimer’s disease
    Investigated Drugs:
    • 2-(6-[18F]Fluoro-Pyridin-3-Yl)-9H-Dipyrido[2,3-B:3′,4′-D]Pyrrole
    • Flutemetamol (18F)
    Sweden

  • Study on Neurodegenerative Diseases Using [18F]RO6958948 for Early Detection and Mapping in At-Risk Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neurodegenerative disorder
    Investigated Drugs:
    • 2-(6-[18F]Fluoro-Pyridin-3-Yl)-9H-Dipyrido[2,3-B:3′,4′-D]Pyrrole
    Sweden

  • Study on the Effects of Dexmedetomidine on Brain Fluid Flow and Activity in Patients with Neurodegenerative Diseases, Delirium, or Acute Neurological Conditions

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Delirium
    • Nervous system disorder
    • Neurodegenerative disorder
    Investigated Drugs:
    • Dexmedetomidine
    Finland

  • A Study of Donanemab in People With Early Symptomatic Alzheimer’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dementia
    • Mental disorder
    • Neurodegenerative disorder
    Investigated Drugs:
    • Donanemab
    • Florbetapir (18F)
    • Flortaucipir (18F)
    Poland Spain

  • Study of Latozinemab for Patients with Neurodegenerative Diseases Who Previously Participated in a Latozinemab Study

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Neurodegenerative disorder
    Investigated Drugs:
    • Latozinemab
    Belgium France Germany Italy The Netherlands Portugal +1

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!